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ABSTRACT 
 
An efficient and environmentally friendly methodology for the solvent-free synthesis of -amino 
nitrile-derived ureas from -amino acid-based amino nitriles has been developed. At room 
temperature no epimerization was observed in the resulting ureas, but under MW heating, 
epimerization occurred at the chiral center bearing the cyano group. 
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-Amino nitriles are versatile intermediates for the 
synthesis of multiple building blocks.
1
 In particular, -
amino acid-derived amino nitriles have shown high 
potential for molecular diversity generation.
2
 Thus, we 
have shown their utility in the synthesis of 
pseudopeptides
3
 and diverse chiral heterocyclic 
compounds.
4
  
Among -amino nitrile derivatives, N-acyl-amino-
nitriles have shown to be privileged molecules for the 
search of inhibitors of therapeutically important 
peptidases,
5
 such as dipeptidyl peptidase IV,
6
 prolyl 
oligopeptidases,
7
 and cysteine cathepsins.
8
 More 
concretely,  several -amino nitrile-derived ureas have 
been patented as inhibitors of  cholesteryl ester transfer 
protein
9
 and diverse enzymes,
10
 agents for neurological 
disorders,
11
 pesticides,
12
 or fungicides.
13
 On the other 
hand, -amino nitrile-derived ureas are intermediates in 
the synthesis of diverse pharmacologically active 
hydantoin derivatives from -amino nitriles,14  although 
these intermediates have not been isolated and 
characterized. Therefore, to develop simple and versatile 
methods for the synthesis and identification of N-
(cyanomethyl)ureas is an important goal in synthetic 
organic chemistry, in particular, environmentally friendly 
solvent-free procedures. 
In the context of a medicinal chemistry project focused 
on the search of modulators of protein-protein 
interactions, we required the basic amino acid-derived N-
(cyanomethyl)ureas of general formula A (Scheme 1), 
which were expected to be easily accessible from the 
corresponding -amino nitriles B, by reaction with 
isocyanates. These -amino nitriles B were previously 
obtained by a modified Strecker synthesis as epimeric 
mixtures in the carbon bearing the cyano group, which 
were chromatographically resolved.
15
 
 
 
Scheme 1 
 
The reaction of the -amino nitrile (S)-1a (Scheme 2) 
with two equivalents of phenyl isocyanate was used for 
setting up the methodology. Initially, the synthesis of the 
N-(cyanomethyl)urea (S)-2a was explored in parallel in 
two different solvents, in CH2Cl2 at room temperature and 
in THF at 0 ºC, under described reaction conditions.
14a, 16
 
When the reaction was carried out in THF, 86% of urea 
(S)-2a was isolated after 3 days of reaction. However, in 
the case of the reaction in CH2Cl2, after 5 days, the 
starting amino nitrile (S)-1a remained unaltered, but, after 
3 additional days, when the solvent had accidentally 
evaporated, the TLC and HPLC analysis of the crude 
reaction mixture showed the presence of 60 % of (S)-2a. 
This result induced us to study the reaction under solvent-
free conditions. These involved the mixture and 
homogenization of reagents with a minimum amount of 
dry CH2Cl2, followed by evaporation of the solvent under 
argon. As shown in Table 1, under these conditions, a 98 
% of the wished urea (S)-2a was obtained after 48 h.  
 
 
Scheme 2. Synthesis of the N-(cyanomethyl)ureas 2a from the 
-amino nitrile (S)-1a as indicated in Table 1 
 
 
 
Table 1. Influence of reaction conditions on the synthesis of the 
N-(cyanomethyl)ureas 2a 
entry 
amino nitrile    (cyanomethyl)urea 
nº solvent t (ºC) t  nº  (%)a 
1 (S)-1a THF 0 3 d (S)-2a 86 
2 (S)-1a CH2Cl2 rt 5 d (S)-2a 0 
3 (S)-1a - rt 
48 
h 
(S)-2a 98 
4b (S)-1a CH2Cl2 80 2 h (S)-2a 0 
5b (S)-1a - 80 2 h (RS)-2a 98c 
6b (R)-1a - 80 2 h (RS)-2a 98c 
a Isolated yield. b Microwave irradiation. c [(R):(S)] epimer ratio ≈ 1:1 
 
 
Next, with the aim of decreasing the reaction time, the 
reaction was carried out under heating at 80 ºC by 
microwave irradiation. When this heating was applied 
using CH2Cl2 as solvent, the starting amino nitrile (S)-1a 
was recovered unaltered after 2h (Table 1, entry 4). 
However, when the microwave heating was applied to the 
solvent-free reaction mixture, a 98 % of the epimeric 
mixture of ureas (RS)-2a was obtained. A similar result 
was obtained when the starting amino nitrile was the 
epimer (R)-1a (Table 1, entry 6). In both cases, the HPLC 
analysis of the crude reaction mixture showed the 
presence of the two epimeric ureas (R)- and (S)-2a with tR 
of 27.7 and 27.5 min, respectively, in an ≈ 1:1 ratio and 
traces of the corresponding starting amino nitrile (R)- or 
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(S)-1a at 23.28 or 23.89 min. These data indicated 
epimerization in the (cyanomethyl)urea at the carbon 
bearing the cyano group, which had not occurred in the 
starting amino nitriles (R)- and (S)-1a. These results were 
confirmed in the 
1
H NMR analysis of the crude reaction 
products. As shown in Scheme 3, the higher propensity of 
N-(cyanomethyl)ureas to epimerize, with respect to the 
corresponding -amino nitrile, could be explained due to 
the electron attracting effect of the ureido group, which 
would increase the acidity of the proton in position  to 
the cyano group, facilitating the formation of the 
tautomeric ketimine species 3a, which would revert to 
give the epimeric mixture of N-(cyanomethyl)ureas (RS)-
2a. Both pure isolated epimers (R)- and (S)-2a 
epimerized by heating at 80 ºC under MW irradiation, 
although this epimerization was slower in (S)-2a than in 
(R)-2a (180 vs. 120 min for complete epimerization). 
However, under similar conditions, the starting amino 
nitriles (R)- and (S)-1a were recovered without 
epimerization. In relation to these results, two recent 
reports, on the enzymatic resolution of -amino nitriles, 
reported the complete racemization of -acylamino 
nitriles at 40 ºC, while no racemization at all was 
observed in their respective -amino nitriles.17After 
chromatographic resolution of the epimeric mixtures 
(RS)-2a, each of the resulting epimer showed the same 
optical rotation as (R)-2a and (S)-2a obtained under free 
epimerization conditions. This result indicated that 
epimerization had taken place at the carbon bearing the 
cyano group and not at the carbon bearing the N-benzyl 
carboxamide group, as in that case the epimerization 
compounds would be enantiomers of (R)-2a and (S)-2a 
with the same optical rotation value, but opposite sign. 
 
Scheme 3. Proposed mechanism of epimerization of N-(cyanomethyl)ureas 
 
 
 In view of the results shown in Table 1, we considered 
that the best conditions for the epimerization-free 
synthesis of N-(cyanomethyl)ureas from -amino nitriles 
were the solvent-free reaction with two equivalents of 
isocyanate at room temperature. These conditions were 
applied for the synthesis of ureas 2a-d and 4-6a as shown 
in Scheme 4 and Table 2. When, due to problems of 
resolution, the starting -amino nitrile was an epimeric  
mixture, to optimize the reaction time, the synthesis was 
carried out under MW irradiation. 
 
Scheme 4 
 
 
 
 
Table 2. Synthesis of N-(cyanomethyl)ureas 2a-d from  -
amino nitriles 1a-d 
-amino nitrile  (cyanomethyl)urea 
entry Nº methoda  Nº R2  (%)b 
1 (R)-1a B  (R)-2a Ph 96 
2 (S)-1a B  (S)-2a Ph 86 
3 (RS)-1ac C  (RS)-2a Ph 95 
4 (R)-1a B  (R)-4a Bn 95 
5 (S)-1a B  (S)-4a Bn 93 
6 (RS)-1ac C  (RS)-4a Bn 97 
7 (R)-1a B  (R)-5a 4-MeO-Ph-(CH2)2 94 
8 (S)-1a B  (S)-5a 4-MeO-Ph-(CH2)2 93 
9 (RS)-1ac C  (RS)-5a 4-MeO-Ph-(CH2)2 90 
10 (S)-1a B  (S)-6a 4-F-Ph-(CH2)2 91 
11 (RS)-1ac C  (RS)-6a 4-F-Ph-(CH2)2 96 
12 (RS)-1bd C  (RS)-2b Ph 95 
13 (RS)-1cc C  (RS)-2c Ph 92 
14 (RS)-1dc C  (RS)-2d Ph 97 
a Method B: Solvent-free, rt, 2-3 days; Method C: MW 80 ºC, 2-3 h.  
b Isolated yield. c [(R):(S)] epimer ratio = 1:1. d [(R):(S)] epimer ratio = 
1:3. 
 
 
The methodology was also applied to the methyl ester 
-amino nitriles (R)- and (S)-7a,b, derived from ornithine 
(a) and lysine (b) (Scheme 5). In these cases, the HPLC-
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MS analyses of the crude reaction mixtures indicated that 
the reactions were significantly slower and, after 7 days, 
they showed 75 % of conversion to give 43 % of the 
respective N-(cyanomethyl)urea (R)- and (S)-8a,b along 
with 33 % of the corresponding hydantoin derivative (R)- 
and (S)-9a,b. However, when the reactions were carried 
out under MW irradiation at 80 ºC, after 2h, the HPLC-
MS analyses of the crude reaction mixtures showed the 
formation of a 90 % of ureas (R)- and (S)-8a,b, and traces 
of the corresponding hydantoin. After silica gel column 
chromatography, the ureas cyclized completely to the 
respective hydantoin derivatives (R)- and (S)-9a,b, which 
were isolated free of epimerization in 70-78 % yield.
 
 
 
Scheme 5 
 
 
In conclusion, we have developed an environmentally 
friendly solvent-free methodology for the synthesis of 
amino acid-based chiral highly functionalized N-
(cyanomethyl)ureas with high potential for the generation 
of molecular diversity in drug discovery. Although the 
synthesis can be activated by MW heating, precaution 
must be taken as it can induce epimerization at the chiral 
center bearing the cyano group.  
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